Production of Recombinant Antimicrobial Polymeric Protein Beta Casein-E 50-52 and Its Antimicrobial Synergistic Effects Assessment with Thymol

Molecules. 2017 May 31;22(6):822. doi: 10.3390/molecules22060822.

Abstract

Accelerating emergence of antimicrobial resistance among food pathogens and consumers' increasing demands for preservative-free foods are two contemporary challenging aspects within the food industry. Antimicrobial packaging and the use of natural preservatives are promising solutions. In the present study, we used beta-casein-one of the primary self-assembly proteins in milk with a high polymeric film production capability-as a fusion partner for the recombinant expression of E 50-52 antimicrobial peptide in Escherichia coli. The pET21a-BCN-E 50-52 construct was transformed to E. coli BL21 (DE3), and protein expression was induced under optimized conditions. Purified protein obtained from nickel affinity chromatography was refolded under optimized dialysis circumstances and concentrated to 1600 µg/mL fusion protein by ultrafiltration. Antimicrobial activities of recombinant BCN-E 50-52 performed against Escherichia coli, Salmonella typhimurium, Listeria monocytogenes, Staphylococcus aureus, Aspergillus flavus, and Candida albicans. Subsequently, the synergistic effects of BCN-E 50-52 and thymol were assayed. Results of checkerboard tests showed strong synergistic activity between two compounds. Time-kill and growth kinetic studies indicated a sharp reduction of cell viability during the first period of exposure, and SEM (scanning electron microscope) results validated the severe destructive effects of BCN E 50-52 and thymol in combination on bacterial cells.

Keywords: E 50-52; antimicrobial activity; beta-casein; synergism; thymol.

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Anti-Infective Agents / metabolism
  • Anti-Infective Agents / pharmacology*
  • Aspergillus flavus / drug effects
  • Aspergillus flavus / growth & development
  • Bacteriocins / biosynthesis
  • Bacteriocins / genetics
  • Bacteriocins / pharmacology*
  • Candida albicans / drug effects
  • Candida albicans / growth & development
  • Caseins / biosynthesis
  • Caseins / genetics
  • Caseins / pharmacology*
  • Cattle
  • Cloning, Molecular
  • Drug Combinations
  • Drug Synergism
  • Escherichia coli / drug effects
  • Escherichia coli / genetics
  • Escherichia coli / metabolism
  • Food Packaging / methods
  • Gene Expression
  • Genetic Vectors / chemistry
  • Genetic Vectors / metabolism
  • Humans
  • Listeria monocytogenes / drug effects
  • Listeria monocytogenes / growth & development
  • Microbial Sensitivity Tests
  • Recombinant Fusion Proteins / biosynthesis
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / pharmacology*
  • Salmonella typhimurium / drug effects
  • Salmonella typhimurium / growth & development
  • Staphylococcus aureus / drug effects
  • Staphylococcus aureus / growth & development
  • Thymol / pharmacology*

Substances

  • Anti-Infective Agents
  • Bacteriocins
  • Caseins
  • Drug Combinations
  • Recombinant Fusion Proteins
  • bacteriocin E 50-52, Enterococcus faecium
  • Thymol